BiotechTube
FairJourney Biologics

FairJourney Biologics

Porto, Portugal· Est.
fjbio.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $15M

Overview

FairJourney Biologics is a leading antibody discovery and biologics services CRO headquartered in Porto, Portugal. The company leverages a suite of advanced technologies, including proprietary mammalian display platforms, yeast display, and superhuman libraries, to deliver high-quality, tailored antibody solutions for its clients. It has established a strong reputation for speed, expertise, and reliability, as evidenced by testimonials from prominent biopharma partners like Daiichi Sankyo, argenx, and Merus. Beyond its core services, FairJourney also organizes a major industry conference, The Antibody Series, reinforcing its position as a key player in the antibody community.

AntibodiesBiologicsDrug Delivery

Technology Platform

Proprietary mammalian display (Explorer Libraries), yeast display, superhuman synthetic libraries, and integrated services for antibody discovery, engineering, production, and characterization including cryo-EM.

Funding History

1
Total raised:$15M
Series A$15M

Opportunities

The growing global demand for antibody therapeutics and complex biologics drives expansion for specialized CROs.
FairJourney's end-to-end model and European cost base position it well to capture market share from both virtual biotechs and large pharma seeking external innovation.
The expansion of its technology suite (e.g., into yeast display, cryo-EM) opens new service revenue streams.

Risk Factors

Revenue is tied to client R&D budgets, making it susceptible to biopharma funding cycles.
The antibody CRO landscape is intensely competitive, requiring constant innovation to maintain an edge.
The service-based model, while providing steady revenue, lacks the high upside of owning therapeutic IP.

Competitive Landscape

FJB competes in a crowded global market for antibody discovery services against large, public CROs (e.g., Lonza, Labcorp), specialized antibody platforms (e.g., Abzena, BioAtla), and numerous regional players. Its differentiation lies in its integrated mammalian display expertise, end-to-end service offering, strong client testimonials, and its unique industry conference which builds community and brand loyalty.

More companies in Biologics / Biosimilars →More companies in Portugal →